Streetbeat News

DOCS

Doximity, Inc.

https://www.doximity.com

Industry

Medical - Healthcare Information Services

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Canaccord Genuity has maintained a Buy rating on Doximity and raised its price target from $37 to $40, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 11:57 am

JP Morgan analyst Anne Samuel maintains a Neutral rating on Doximity (NYSE:DOCS) but raises the price target from $27 to $30.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:01 pm

In the last three months, 8 analysts have shared their evaluations of Doximity (NYSE:DOCS), revealing diverse outlooks. The average 12-month price target has risen by 8.51% to $31.0. Analysts have adjusted their ratings and price targets, with some raising and others lowering their expectations. Doximity has shown strong financial performance with impressive revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

August 14, 2024 | 3:00 pm

Truist Securities has reiterated its Hold rating on Doximity (NYSE:DOCS) and raised the price target from $31 to $35.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2024 | 2:05 pm

U.S. stocks settled higher on Friday despite recording losses earlier in the week. The Dow and Nasdaq fell by 0.6% and 0.18% respectively over the week. Doximity, Inc. (DOCS) shares surged 38.7% after strong Q1 results and positive FY24 revenue guidance. Iteris, Inc. (ITI) shares jumped 63.6% following an acquisition announcement. Investors are awaiting earnings results from Monday.com Ltd. (MNDY), Sun Life Financial Inc. (SLF), and KE Holdings Inc. (BEKE). The CNN Money Fear and Greed index remains in the 'Extreme Fear' zone.

Portfolio Pulse from Avi Kapoor

August 12, 2024 | 7:39 am

Doximity, Inc. (NYSE:DOCS) shares surged over 35% after reporting better-than-expected Q1 FY2024 financial results, including a 17% YoY revenue increase to $126.68 million and adjusted EPS of 28 cents. The company also issued strong revenue guidance for Q2 and FY2024, leading to several analyst upgrades and price target increases.

Portfolio Pulse from Vaishali Prayag

August 09, 2024 | 6:57 pm

U.S. stocks traded mixed with the Nasdaq Composite gaining over 50 points. Crude oil prices rose, and the number of active U.S. oil rigs increased by three. Blend Labs, Doximity, and Iteris shares surged following positive financial results and acquisition news, while AN2 Therapeutics, Vicinity Motor, and Meta Materials saw significant declines due to negative developments.

Portfolio Pulse from Avi Kapoor

August 09, 2024 | 6:38 pm

Top Wall Street analysts have updated their outlooks on several US-listed companies, including Zillow Group, The Trade Desk, Martin Marietta Materials, YETI Holdings, Diebold Nixdorf, Doximity, Mitek Systems, Five9, CF Industries, and Alta Equipment Group. Notable changes include price target increases for Zillow, The Trade Desk, Diebold Nixdorf, Doximity, and CF Industries, and price target cuts for Martin Marietta Materials, YETI Holdings, Mitek Systems, Five9, and Alta Equipment Group.

Portfolio Pulse from Avi Kapoor

August 09, 2024 | 5:55 pm

Expedia Group, Inc. (NASDAQ:EXPE) and several other major stocks saw significant gains on Friday following better-than-expected financial results. Expedia reported quarterly earnings of $3.51 per share, beating the consensus estimate of $3.06, and quarterly sales of $3.558 billion, surpassing the estimate of $3.534 billion. Other notable gainers include Blend Labs, Inc. (NYSE:BLND), Doximity, Inc. (NYSE:DOCS), ADMA Biologics, Inc. (NASDAQ:ADMA), Sweetgreen, Inc. (NYSE:SG), Evolent Health, Inc. (NYSE:EVH), Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), CarGurus, Inc. (NASDAQ:CARG), IAMGOLD Corporation (NYSE:IAG), Genpact Limited (NYSE:G), Paymentus Holdings, Inc. (NYSE:PAY), DigitalOcean Holdings, Inc. (NYSE:DOCN), Rocket Lab USA, Inc. (NASDAQ:RKLB), Akamai Technologies, Inc. (NASDAQ:AKAM), The Trade Desk, Inc. (NASDAQ:TTD), DXC Technology Company (NYSE:DXC), and Eli Lilly and Company (NYSE:LLY).

Portfolio Pulse from Avi Kapoor

August 09, 2024 | 4:51 pm

Evercore ISI Group analyst Elizabeth Anderson maintains an In-Line rating on Doximity (NYSE:DOCS) and raises the price target from $29 to $34.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2024 | 4:23 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.